Last updated: July 7, 2023
Sponsor: University Hospital, Bordeaux
Overall Status: Active - Recruiting
Phase
N/A
Condition
Thrombocytopenia And Thrombocytopenia Prevention
Immune (Idiopathic) Thrombocytopenic Purpura (Itp)
Lupus
Treatment
data collection
Clinical Study ID
NCT05937828
CHUBX 2023/08
Ages < 17 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Diagnosis of ITP, AIHA, Evans Syndrome
- Onset before the age of 18
Exclusion
Exclusion Criteria:
- Opposition of legal representative or to data collection
Study Design
Total Participants: 3500
Treatment Group(s): 1
Primary Treatment: data collection
Phase:
Study Start date:
September 01, 2010
Estimated Completion Date:
December 31, 2029
Study Description
Connect with a study center
CHU Amiens Picardie Service d' Onco-Immuno-Hématologie Pédiatrique
Amiens,
FranceActive - Recruiting
CHU d'Angers Unité d'Hémato-Oncologie Pédiatrique
Angers,
FranceActive - Recruiting
BESANCON CHU de Besançon Hôpital Jean MINJOZ Unité d'Hémato-Oncologie Pédiatrique, Pédiatrie 1
Besançon,
FranceActive - Recruiting
CHU de Bordeaux - Unité d'Hématologie et d'Oncologie pédiatrique
Bordeaux,
FranceActive - Recruiting
CHU BREST Hôpital Morvan Unité d'Onco-Hématologie
Brest,
FranceActive - Recruiting
CHU de Caen Unité d'Onco-Hématologie
Caen,
FranceActive - Recruiting
CHU de Clermont Ferrand
Clermont-Ferrand,
FranceActive - Recruiting
APHP Hôpital Bicêtre Service de Pédiatrie générale
Paris,
FranceActive - Recruiting
CH de Cornouaille Service de Pédiatrie
Quimper,
FranceActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.